Controlled trial of antimycobacterial therapy in Crohn's disease. Clofazimine versus placebo (Q70123445)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007362%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

title

Controlled trial of antimycobacterial therapy in Crohn's disease. Clofazimine versus placebo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007362%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference

1 reference

1 reference

1 reference

N H Afdhal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007362%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

A Long

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007362%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

J Lennon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007362%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

J Crowe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007362%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

D P O'Donoghue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007362%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

publication date

1 April 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007362%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

8 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007362%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007362%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007362%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

page(s)

449-453

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007362%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01298873

8 October 2019

exact match

0 references

cites work

Mycobacteria and inflammatory bowel disease. Results of culture

1 reference

12 December 2020

Diet in the management of Crohn's disease

1 reference

12 December 2020

Activity of rifabutin alone or in combination with clofazimine or ethambutol or both against acute and chronic experimental Mycobacterium intracellulare infections

1 reference

12 December 2020

Antimycobacterial therapy ineffective in Crohn's disease after a year

1 reference

12 December 2020

Ruminant paratuberculosis (Johne's disease): the current status and future prospects

1 reference

12 December 2020

Treatment of Leprosy with a Phenazine Derivate (B 663 or G 30 320) - Clofazimine

1 reference

12 December 2020

Lamprene (clofazimine) in leprosy. Basic information

1 reference

12 December 2020

Mycobacteria as a possible cause of inflammatory bowel disease

1 reference

12 December 2020

Experimental disease in infant goats induced by a Mycobacterium isolated from a patient with Crohn's disease. A preliminary report

1 reference

12 December 2020

Controlled trial of rifampicin and ethambutol in Crohn's disease

1 reference

12 December 2020

Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease

1 reference

12 December 2020

Effect of the rimino phenazine B663 (G30320) on Mycobacterium johnei infection and reinfection in sheep. I. Bacteriology and hypersensitivity

1 reference

12 December 2020

Remission of Crohn's disease with antimycobacterial chemotherapy

1 reference

12 December 2020

Terminal ileitis associated with Mycobacterium avium-intracellulare infection in a homosexual man with acquired immune deficiency syndrome.

1 reference

12 December 2020

Crohn's disease-isolated mycobacteria are identical to Mycobacterium paratuberculosis, as determined by DNA probes that distinguish between mycobacterial species

1 reference

12 December 2020

Clofazimine treatment of cows naturally infected with Mycobacterium paratuberculosis

1 reference

12 December 2020

Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn's disease

1 reference

12 December 2020

In vitro antimicrobial susceptibility of a Mycobacterium sp. isolated from patients with Crohn's disease

1 reference

12 December 2020

Bactericidal activities of various antimicrobial agents against human and animal isolates of Mycobacterium paratuberculosis

1 reference

12 December 2020

Clofazimine-mediated regulation of human polymorphonuclear leukocyte migration by pro-oxidative inactivation of both leukoattractants and cellular migratory responsiveness

1 reference

12 December 2020

Nontuberculous mycobacterial lung disease. Substantiation of a less aggressive approach

1 reference

12 December 2020

Gastro-intestinal tuberculosis. A 10-year review

1 reference

12 December 2020

Evidence for a transmissible factor in Crohn's disease

1 reference

12 December 2020

Clofazimine-mediated stimulation of prostaglandin synthesis and free radical production as novel mechanisms of drug-induced immunosuppression

1 reference

12 December 2020

Oxygen metabolism in phagocytes of leprotic patients: enhanced endogenous superoxide dismutase activity and hydroxyl radical generation by clofazimine

1 reference

12 December 2020

Quadruple antimycobacterial chemotherapy in Crohn's disease: results at 9 months of a pilot study in 20 patients.

1 reference

12 December 2020

A co-operative numerical analysis of nonscoto- and nonphotochromogenic slowly growing mycobacteria

1 reference

12 December 2020

Further animal evidence of a transmissible agent in Crohn's disease

1 reference

12 December 2020

Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS

1 reference

12 December 2020

Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease

1 reference

12 December 2020

Antimycobacterial chemotherapy in two cases of inflammatory bowel disease

1 reference

12 December 2020

Crohn's disease. New concepts of pathogenesis and current approaches to treatment

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01298873

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2007362%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

1 reference